The gut-skin axis in health and disease: A paradigm with therapeutic implications

BioEssays

Volumn 38, Issue 11, 2016, Pages 1167-1176

  O'Neill, Catherine A ^a   Monteleone, Giovanni ^b   McLaughlin, John T ^a   Paus, Ralf ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

diet; gut; microbiota; probiotic; skin

Indexed keywords

ARTICLE; ATOPIC DERMATITIS; CENTRAL NERVOUS SYSTEM; COMORBIDITY; DIET; DYSBIOSIS; HUMAN; INTESTINE; INTESTINE FLORA; LACTOBACILLUS REUTERI; METABOLIC CAPACITY; MICROBIAL METABOLISM; NEUROENDOCRINE SYSTEM; NONHUMAN; SKIN; SKIN ALLERGY; SKIN FLORA; SKIN SENSITIVITY; BACTERIUM; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BACTERIA; DIET; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINES; SKIN;

EID: 84992456177     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201600008     Document Type: Article

References (120)

1. Barrett KE, Ghishan FK, Merchant JL, Said HM, et al. 2013. Physiology of the gastrointestinal tract. V1–2. New York: Elsevier.
2. Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, et al. 2012. Fitzpatricks Dermatology in general medicine. New York: McGraw Hill Medical.
3. Goldman L, Schafer AI. 2015. Goldman–Cecil Medicine, 25th edition. New York: Elsevier Saunders.
4. Stokes JH, Pillsbury DH. 1930. The effect on the skin of emotional and nervous states: theoretical and practical consideration of a gastrointestinal mechanism. Arch Dermatol Syphilol 22: 962–93.
5. Bowe WP, Logan AC. 2011. Acne vulgaris, probiotics and the gut-skin-brain axis − back to the future. Gut Pathogens 3: 1–1.
6. Levkovich T, Poutahidis T, Smillie C, Varian BJ, et al. 2013. Probiotic bacteria induce a ‘glow of health'. PLoS ONE 8: e53867.
7. Wu XR, Mukewar S, Kiran RP. 2013. Risk factors for peristomal pyoderma gangrenosum complicating inflammatory bowel disease. J Crohns Colitis 7: e171–7.
8. Thrash B, Patel M, Shah KR. 2013. Cutaneous manifestations of gastrointestinal disease: part II. J Am Acad Dermatol 68: 211.e1–33.
9. Bonciani D, Verdelli A, Bonciolini V, D'Errico A, et al. 2012. Dermatitis herpetiformis: from the genetics to the development of skin lesions. Clin Dev Immunol 012: 239691.
10. Wu JJ, Nguyen TU, Poon KY, Herrington LJ. 2012. The association of psoriasis with automimmune disease. J Am Acad Dermatol 67: 924–30.
11. Zandi S, Shamsadini S, Zahedi MJ, Hyatbaksh M. 2003. Helicobacter pylori and rosacea. East Mediterr Health J 9: 167–71.
12. Parodi A, Paolino S, Greco A. 2008. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol 6: 759–64.
13. Ramos-E-Silva M, Carvalho JC, Carneiro SC. 2011. Cutaneous paraneoplasia. Clin Dermatol 29: 541–7.
14. Shah KR, Boland CR, Patel M, Thrash B, et al. 2013. Cutaneous manifestations of gastrointestinal disease: part I. J Am Acad Dermatol 68: 189.e1–21.
15. Metchnikoff E. 1910. In Mitchell P, ed; The Prolongation of Life. Optimistic Studies. NewYork: GP Putnam's Sons. p. 96.
16. Poutahidis T, Kearney SM, Levkovich T, Qi P, et al. 2013. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PloS ONE 8: e78898.
17. Powrie F, Maloy KJ. 2003. Regulating the regulators. Science 299: 1030–1.
18. Lee YK, Mazmanian SK. 2010. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330: 1768–73.
19. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. 2010. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490–500.
20. Gueniche A, Philippe D, Bastien P, Reuteler G, et al. 2014. Randomised double-blind placebo-controlled study of the effect of Lactobacillus paracasei NCC 2461 on skin reactivity. Benef Microbes 5: 137–45.
21. Hashimoto K. 2000. Regulation of keratinocyte function by growth factors. J Dermatol Sci 24: S46–50.
22. Pasonen-Seppanen S, Karvinen S, Torronen K, Hyttinen JM, et al. 2003. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. J Invest Dermatol 120: 1038–44.
23. Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, et al. 2004. Lactobacillus casie reduces CD8+ T cell mediated skin inflammation. Eur J Immunol 34: 2520–8.
24. Floch MH, Walker WA, Madsen K, Sanders ME, et al. 2011. Recommendations for probiotic use – 2011 update. J Clin Gastroenterol 45: S168–71.
25. Gueniche A, Benyacoub J, Buetler TM, Smola H, et al. 2006. Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur J Dermatol 16: 511–7.
26. Gueniche A, Bastien P, Ovigne JM, Mermici M, et al. 2010. Bifidobacterium longum lysate, a new ingredient for reactive skin. Ecp Dermatol 16: 511–7.
27. Grice EA, Kong HH, Conlan S, et al. 2009. Topographical and temporal diversity of the human skin microbiome. Science 29: 1190–2.
28. Lai Y, Di Nardo A, Nakatsuji T, Lichtle A, et al. 2009. Commensal bacteria regulate toll-like receptor 3-dependent inflamation after skin injury. Nat Med 15: 1377–82.
29. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, et al. 2012. Compartmentalized control of skin immunity by resident commensals. Science 337: 1115–9.
30. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, et al. 2012. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 129: 434–40.
31. Nylund L, Nermes M, Isolauri E, Salminen S, et al. 2015. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate producing bacteria. Allergy 70: 241–4.
32. Song H, Yoo Y, Hwang J, Na YC, et al. 2016. Faecalibacterium prausnotzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J Allergy Clin Immunol 137: 852–60.
33. Dawson LF, Donahue EH, Cartman ST, Barton RH, et al. 2011. The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. BMC Microbiol 11: 86.
34. Miyazaki K, Masuoka N, Kano M, Lizuka R. 2014. Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota. Benef Microbes 5: 121–8.
35. Ramírez-Boscá A, Navarro-López V, Martínez-Andrés A, Such J, et al. 2015. Identification of bacterial DNA in the peripheral blood of patients with active psoriasis. JAMA Dermatol 151: 670–1.
36. Balmer ML, Slack E, de Gottardi A, Lawson MA, et al. 2015. The liver may act as a firewall mediating mutualism between the host and its commensal microbiota. Sci TranslMed 6: 237.
37. Wang M, Karlsson C, Olsson C, Adlerberth I, et al. 2008. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 121: 129–34.
38. Bisgaard H, Li N, Bonnelykke K, Chawes BL, et al. 2011. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 128: 646–52.
39. Elazab N, Mendy A, Gasana J, Vieira ER, et al. 2013. Probiotic administration in early llife, atopy, and asthma: a meta analysis of clinical trials. Pediatrics 132: e666–76.
40. Gore C, Munro K, Lay C, Bibioni R, et al. 2008. Bifidobacteriu psuedocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol 121: 135–40.
41. Sepp E, Julge K, Mikelsaar M, Bjorksten B. 2005. Intestinal microbiota and immunoglobulin E responses in 5year old Estonian children. Clin Exp Allergy 35: 1141–6.
42. Mah KW, Bjorksten B, Lee BW, Van Bever HP, et al. 2006. Distinct patterns of commensal gut microbiota in toddlers with ezema. Int Arch Allergy Immunol 140: 157–63.
43. Rautava S, Kainonen E, Salminen S, Isolauri E. 2012. Maternal probiotic supplenetstion during pregnancy and breast feeding reduces the risk of eczema to the infant. J Allergy Clin immunol 130: 1355–60.
44. Collado MC, Rautava S, Aakko J, Isolauri E, et al. 2016. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep 6: 23129.
45. Zanvit P, Konkel JE, Jiao X, Kasagi S, et al. 2015. Antibiotics in neonatal life increase susceptibility to experimental psoriasis. Nat Commun 6: 8424.
46. Groeger D, O'Mahony L, Murphy EF, Bourke JF, et al. 2013. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 4: 325–39.
47. Gallo RL, Nakatsuji T. 2011. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol 131: 1974–80.
48. Cordain L, Lindberg S, Hurtado M, Hill K, et al. 2002. Acne vulgaris: a disease of western civilization. Arch Dermatol 138: 1584–90.
49. Burris J, Rietkerk W, Woolf K. 2014. Relationships of self-reported dietary factors and perceived acne severity in a cohort of New York youg adults. J Acad Nutr Diet 114: 384–92.
50. Grossi E, Cazzniga S, Crotti S, Naldi L, et al. 2014. The constellation of dietary factors in adolescent acne: a semantic connectivity map approach. J Eur Aad Dermatol Venereol 30: 96–100.
51. Agamia NF, Abdallah DM, Sorour O, Morad B, et al. 2016. Skin expression of mammalian target of rapamycin (mTOR) forkhead box transcription factor Fox O1_ and serum insulin-like growth factor-1 (IGF-1) in patients with acne vulgaris and their relationship with diet. Br J Dermatol 174: 1299–307.
52. Monfrecola G, Lembo S, Caiazzo G, De Vita V, et al. 2015. Mechanistic target of rapamycin (mTOR1) expression is increased in acne patients skin. Exp Dermatol 25: 153–5.
53. Melnik BC. 2015. Western diet induced imbalances of FoxO1 and mTORC1 signalling promote the sebofollicular inflammasomopathy acne vulgaris. Exp Dermatol 25: 103–4.
54. Smith TM, Gilliland K, Clawson GA, Thiboutot D. 2008. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol 128: 1286–93.
55. McGinley KJ, Webster GF, Ruggieri MR, Leyden JJ. 1980. Regional variations in density of cutaneous propionibacteria: correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol 12: 672–5.
56. Jahns AC, Lundskog B, Ganceviciene R, Palmer RH, et al. 2012. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol 167: 50–8.
57. Zouboulis CC, Jourdan E, Picardo M. 2014. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol 28: 527–32.
58. Hammerberg C, Bata-Csorgo Z, Voorhees JJ, Cooper KD. 1998. IL-1 and IL-1 receptor antagonist regulation during keratinocyte cell cycle and differentiation in normal and psoriatic epidermis. Arch Dermatol Res 290: 367–74.
59. Eady EA, Goodwin CE, Cove JH, Ingham E, et al. 1991. Inflammatory levels of interleukin 1 alpha are present in the majority of open comedones in acne vulgaris. Arch Dermatol 127: 1238–9.
60. Ingham E, Eady EA, Goodwin CE, Cove JH, et al. 1992. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 98: 895–901.
61. Fabbrocini G, Izzo R, Faggiano A, Del Prete M, et al. 2016. Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. Clin Exp Dermatol 41: 38–42.
62. Manam S, Tsakok T, Till S, Flohr C. 2014. The association between atopic dermatitis and food allergy in adults. Curr Opin Allergy Clin Immunol 14: 423–9.
63. Bartnikas LM, Gurish MF, Burton OT, Leisten S, et al. 2013. Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis. J Allergy Clin Immunol 131: 451–60.
64. Asai Y, Greenwood C, Hull PR, Alizadehfar R, et al. 2013. Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status. J Allergy Clin Immunol 132: 239–42.
65. Fox AT, Sasieni P, Du Toit G, Syed H, et al. 2009. Household peanut consumption as a risk factor for the development of peanut allergy. J Allergy Clin Immunol 123: 417–23.
66. Witteman AM, van Leeuwen J, van der Zee J, Aalberse RC. 1995. Food allergens in house dust. Int Arch Allergy Immunol 107: 566–8.
67. Du Toit G, Roberts G, Sayre PH, Bahnson HT, et al. 2015. Randomised trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 372: 803–13.
68. Oyoshi MK, Elkhal A, Scott JE, Wurbel MA, et al. 2011. Epicutaneous challenge of orally immunised mice redirects antigen-specific gut-homing T cells to the skin. J Clin Invest 121: 2210–20.
69. Giampieri F, Alvarez-Suarez JM, Mazzoni L, Forbes-Hernandez TY, et al. 2014. Polyphenol-rich strawberry extract protects human dermal fibroblasts against hydrogen peroxide oxidative damage and improves mitochondrial functionality. Molecules 19: 7798–816.
70. Rhodes LE, Darby G, Massey KA, Clarke KA, et al. 2013. Oral green tea catechin metabolites are incorporated into human skin and protect against UV radiation-induced cutaneous inflammation in association with reduced production of pro-inflammatory eicosanoid 12-hydroxyeicosatetraenoic acid. Br J Nutr 110: 891–900.
71. Siddiqui IA, Bharali DJ, Nihal M, Adhami VM, et al. 2014. Excellent anti-proliferative and pro-apoptotic effects of (−)-epigallactocatachin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomedicine 10: 1619–26.
72. Kim H, Park J, Tak KH, Bu SY, et al. 2014. Chemopreventive effects of curcumin on chemically induced mouse skin carcinogenesis in BK5.insulin-like growth factor-1 transgenic mice. In Vitro Cell Dev Biol Anim 50: 883–92.
73. Rizwan M, Rodriguez-Blanco I, Harbottle A, Birch-Machin MA, et al. 2011. Tomato paste rich in lycopene protects against cutaneous photodamage in humans in vivo: a randomized controlled trial. Br J Dermatol 164: 154–62.
74. Stahl W, Sies H. 2012. β-Carotene and other carotenoids in protection from sunlight. Am J Clin Nutr 96: 1179S–84S.
75. Yoon HJ, Jang MS, Kim HW, Song DU, et al. 2015. Protective effect of diet supplemented with rice prolamin extract against DNCB-induced atopic dermatitis in BALB/c mice. BMC Complement Altern Med 15: 353.
76. Tundis R, Loizzo MR, Bonesi M, Menichini F. 2015. Potential role of natural compounds against skin ageing. Curr Med Chem 22: 1515–38.
77. Ross AB, Vuong T, Ruckle J, Synal HA, et al. 2011. Lycopene bioavailability and metabolism in humans: an accelerator mass spectrometer study. Am J Clin Nutr 93: 1263–73.
78. Clarke KA, Dew TP, Watson RE, Farrar MD, et al. 2016. Green tea catechins and their metabolites in human skin before and after exposure to ultraviolet radiation. J Nutr Biochem 27: 203–10.
79. Gasperotti M, Passamonti S, Tramer F, Masuero D, et al. 2015. Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination? ACS Chem Neurosci 19: 1341–52.
80. Duenas M, Munoz-Gonzalez, Cueva C, Jimenez-Giron A, et al. 2015. A survey of modulation of gut microbiota by dietary polyphenols. Biomed Res Int 2015: 850902.
81. McFadden RT, Larmonier CB, Shehab KW, Midura-Kiela M, et al. 2015. The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention. Inflamm Bowel Dis 21: 2483–94.
82. Cordain L, Lindeberg S, Hurtado M, Hill K, et al. 2002. Acne vulgaris: a disease of western civilisation. Arch Dermatol 138: 1584–90.
83. Handaus MA, Jomba FA, Ehlayel M. 2016. Allergic disease among children: nutritional prevention and intervention. Ther Clin Risk Manag 12: 361–72.
84. Racine A, Carbonnel F, Chan SS, Hart AR, et al. 2016. Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC study. Inflamm Bowel Dis 22: 345–54.
85. Bradley WD, Zwingelstein C, Rondinone CM. 2011. The emerging role of the intestine in metabolic diseases. Arch Physiol Biochem 117: 165–76.
86. Wood JM, Schallreuter KU. 2008. A plaidoyer for cutaneous enzymology: our view of some important unanswered questions on the contributions of selected key enzymes to epidermal homeostasis. Exp Dermatol 17: 569–78.
87. Kealey T, Williams R, Philpott MP. 1994. The human hair follicle engages in glutaminolysis and aerobic glycolysis: implications for skin, splanchnic and neoplastic metabolism. Skin Pharmacol 7: 41–6.
88. Williams R, Philpott MP, Kealey T. 1993. Metabolism of freshly isolated human hair follicles capable of hair elongation: a glutaminolytic, aerobic glycolytic tissue. J Invest Dermatol 100: 834–40.
89. Paus R, Theoharides TC, Arck PC. 2010. Neuroimmunoendocrine circuity of the ‘brain-skin'connection. Exp Dermatol 19: 401–5.
90. Henke C, Beissner F. 2011. Illustrations of visceral referred pain. “Head-less” head's zones. Schmerz 25: 132–6.
91. Arck P, Handjiski B, Hagen E, Pincus M, et al. 2010. Is there a ‘gut-brain-skin axis'? Exp Dermatol 19: 401–5.
92. Colins S, Verdu E, Denou E, Bercik P. 2000. The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome. Dig Dis 1: 85–9.
93. Gueniche A, Benyacoub JI, Philippe D, Bastien P, et al. 2010. Lactobacilllus paracasei CNCM 1-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Exp Dermatol 20:731–7.
94. Verdu EF, Bercik P, Verma-Gandhu M, Huang XX, et al. 2006. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55: 182–90.
95. Dobrosi N, Toth BI, Nagy G, Dozsa A, et al. 2008. Endocannabnoids enance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor −2 mediated signalling. FASEB J 22: 3685–95.
96. Geboes K, Chamaillard M, Ouwehand A, Leyer G, et al. 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 13: 35–7.
97. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, et al. 2005. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 202: 1023–9.
98. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, et al. 2014. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. Adv Exp Med Biol 817: 195–219.
99. Holzer P, Farzi A. 2014. Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol 817: 195–219.
100. Worthington JJ, Samuelson LC, Grencis RK, McLaughlin JT. 2010. Adaptive immunity alters distinct host feeding pathways during nematode induced inflammation, a novel mechanism in parasite expulsion. Clin Exp Immunol 161: 19–27.
101. Khan WI, Ghia JE. 2012. Enteroendocrine cells in terminal ileal Crohn's disease. J Crohns Colitis 6: 871–80.
102. Moran GW, Pennock J, McLaughlin JT. 2013. Anorexia of aging and gut hormones. Aging Dis 4: 264–75.
103. Thorburn AN, Macia L, Mackay CR. 2014. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity 40: 833–42.
104. Slominski A, Wortsman J, Paus R, Elias PM, et al. 2008. Skin as an endocrine organ. Implications for its function. Drug Discov Today Dis Mech 5: 137–44.
105. Macia L, Tan J, Vieira AT, Leach K, et al. 2015. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 6: 6734.
106. Harris JC, Cottrell SL, Plummer S, Lloyd D. 2001. Antimicrobial properties of Allium sativum (garlic). Appl Microbiol Biotechnol 57: 282–6.
107. Juzeniene A, Moan J. 2012. Beneficial effects of UV radiation other than via vitamin D production. Dermatoendocrinol 4: 109–17.
108. Paus R, Langan EA, Vidali S, Ramot Y, et al. 2014. Neuroendocrinology of the hair follicle: principles and clinical perspectives. Trends Mol Med 20: 559–70.
109. Torki M, Gholamrezaei A, Mirbagher L, Danesh M, et al. 2015. Vitamin D deficiency associated with disease activity in patients with inflammatory bowel diseases. Dig Dis Sci 60: 3085–91.
110. Kammeyer A, Peters CP, Meijer SL, Te Velde AA. 2012. Anti-inflammatory effects of urocanic Acid derivatives in models ex vivo and in vivo of inflammatory bowel disease. ISRN Inflamm 2012: 898153.
111. McFarlane GT, MacFarlane S. 2012. Bacteria, colonuic fermentation and gastrointestinal health. J AOAC Int 95: 50–60.
112. Jin UH, Lee SO, Sridharan G, Lee K, et al. 2014. Microbiome derived tryptophan metabolites and their aryl hydrocarbon receptor dependent agonist and antagonist activities. Mol Pharmacol 85: 777–88.
113. Morita T, McClain SP, Batia LM, Pellegrino M, et al. 2015. HTR7 mediates serotoneurgic acute and chronic itch. Neuron 87: 124–38.
114. Tang WH, Wang Z, Levison BS, Koeth RA, et al. 2013. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 368: 1575–84.
115. Chamcheu JC, Virtanen M, Navsaria H, Bowden PE, et al. 2010. Epidermolysis bullosa simplex due to KRT5 mutations: mutatrion-related differences in cellular fragility and the protective effects of trimethylamine N-oxide in cultured primary kerationocytes. Br J Dermatol 162: 980–9.
116. Cryan JF, Dinan TG. 2012. Mind altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13: 701–12.
117. Yokoyama S, Hiramoto K, Koyama N, Ooi K. 2015. Impairment of skin barrier function via cholinergic signal transduction in a dextran sulphate sodium-induced colitis mouse model. Exp Dermatol 24: 779–84.
118. Akiyama T, Carstens LM, Carstens E. 2011. Transmitters and pathways mediating inhibition of spinal itch-sugnaling neurons by scratching and other counter stmuli. PLoS ONE 6: e22665.
119. Langan EA, Lisztes E, Biro T, Funk W, et al. 2013. Dopamine is a novel direct inducer of catagen in human scalp hair follicles in vitro. Br J Dermatol 168: 520–5.
120. Lee HJ, Park MK, Kim SY, Park Choo HY, et al. 2011. Seretonin induces melanogenesis via serotonin receptor 2A. Br J Dermatol 165: 1344–8.